NIH Active Patent Commercialization Licenses
Download a CSV of the complete license data set.
Reset the Search Filters to go back to the initial display of all records.
Questions? See the NIH Active Patent Commercialization Licenses FAQ.
| ID | Lead IC | Licensee | Territory | Exclusivity | Fiscal Year | Execution Date | Effective Date | Technology ID |
|---|---|---|---|---|---|---|---|---|
| L-324-2017 | NIDDK | Future Medicine Co., Ltd. | Worldwide | Exclusive | 2020 | E-109-2006 | ||
| L-148-2018 | NCI | BravoVax Co., Ltd. | Foreign | Exclusive | 2020 | E-103-2005 | ||
| L-190-2020 | NIAID | Meso Scale Diagnostics, LLC (MSD) | Worldwide | Nonexclusive | 2020 | E-081-2013 E-234-2016 E-086-2020 |
||
| L-195-2020 | NHLBI | XCell Science LLC | Worldwide | Nonexclusive | 2020 | E-342-2013 | ||
| L-202-2020 | NIAID | International AIDS Vaccine Initiative, Inc. | Worldwide | Nonexclusive | 2020 | E-300-2009 E-051-2012 E-034-2018 |
||
| L-188-2020 | NIAID | Teraimmune Inc. | US | Exclusive | 2020 | E-279-2011 | ||
| L-185-2020 | NIMH | Defender Pharmaceuticals, Inc. | Worldwide | Exclusive | 2020 | E-175-2004 | ||
| L-179-2020 | NIAID | BioNTech SE | Worldwide | Nonexclusive | 2020 | E-234-2016 E-086-2020 |
||
| L-030-2017 | NCATS | ConverGene, LLC, Sunterra Bio, Inc. | Worldwide | Exclusive | 2020 | E-004-2016 E-118-2019 |
||
| L-329-2017 | NCI | Abpro | Worldwide | Exclusive | 2020 | E-136-2012 | ||
| L-157-2020 | NIAID | BioLegend, Inc. | Worldwide | Nonexclusive | 2020 | E-168-2016 | ||
| L-098-2018 | NHLBI | T-Cure Bioscience, Inc. | Worldwide | Exclusive | 2020 | E-120-2016 | ||
| L-094-2020 | NCI | Innovative Cellular Therapeutics | Worldwide | Nonexclusive | 2020 | E-170-2009 | ||
| L-136-2020 | NCI | Intima Bioscience Inc. | Worldwide | Exclusive | 2020 | E-275-2002 E-273-2009 E-059-2013 E-085-2013 E-229-2014 E-233-2014 E-149-2015 E-067-2017 E-171-2018 E-173-2018 E-174-2018 |
||
| L-074-2020 | NIAID | China National Biotec Group Company Limited | Foreign | Nonexclusive | 2020 | E-081-2013 E-487-2013 E-064-2016 E-177-2018 |
||
| L-121-2020 | NIAID | Noachis Terra Inc. | Worldwide | Nonexclusive | 2020 | E-234-2016 E-086-2020 |
||
| L-003-2020 | NIAID | Calder Biosciences Inc. | Worldwide | Nonexclusive | 2020 | E-081-2013 | ||
| L-080-2020 | NICHD | Computerized Imaging Reference Systems, Inc. (CIRS) | Worldwide | Nonexclusive | 2020 | E-249-2008 | ||
| L-066-2020 | NIAID | The Native Antigen Company | Worldwide | Nonexclusive | 2020 | E-004-2009 E-057-2011 |
||
| L-248-2015 | NIDCR | InBios International, Inc. | Worldwide | Nonexclusive | 2020 | E-036-2010 | ||
| L-257-2019 | NIAAA | Inversago Pharma, Inc | Worldwide | Exclusive | 2020 | E-282-2012 E-140-2014 |
||
| L-162-2015 | NIAID | Merck Sharp & Dohme Research Labs. | Worldwide | Nonexclusive | 2020 | E-081-2013 E-064-2016 |
||
| L-313-2019 | NICHD | Circumvent Pharmaceuticals, Inc. | Worldwide | Exclusive | 2020 | E-157-2011 | ||
| L-298-2019 | NIAID | GlaxoSmithKline Intellectual Property Limited (GSK) | Worldwide | Exclusive | 2020 | E-131-2015 | ||
| L-315-2019 | NIBIB | Molecular Targeting Technologies, Inc | Worldwide | Exclusive | 2020 | E-150-2016 |